Application Nr Approved Date Route Status External Links
NDA019949 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Diflucan (Fluconazole) Is Indicated For The Treatment Of: Vaginal Candidiasis (Vaginal Yeast Infections Due To Candida ). Oropharyngeal And Esophageal Candidiasis. In Open Noncomparative Studies Of Relatively Small Numbers Of Patients, Diflucan Was Also Effective For The Treatment Of Candida Urinary Tract Infections, Peritonitis, And Systemic Candida Infections Including Candidemia, Disseminated Candidiasis, And Pneumonia. Cryptococcal Meningitis. Before Prescribing Diflucan (Fluconazole) For Aids Patients With Cryptococcal Meningitis, Please See Clinical Studies Section. Studies Comparing Diflucan To Amphotericin B In Non-Hiv Infected Patients Have Not Been Conducted. Prophylaxis: Diflucan Is Also Indicated To Decrease The Incidence Of Candidiasis In Patients Undergoing Bone Marrow Transplantation Who Receive Cytotoxic Chemotherapy And/or Radiation Therapy. Specimens For Fungal Culture And Other Relevant Laboratory Studies (Serology, Histopathology) Should Be Obtained Prior To Therapy To Isolate And Identify Causative Organisms. Therapy May Be Instituted Before The Results Of The Cultures And Other Laboratory Studies Are Known; However, Once These Results Become Available, Anti-Infective Therapy Should Be Adjusted Accordingly.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fluconazole FLUCONAZOLE ZINC4009

Comments